- 1(current)
Q. No.In gene therapy of Adenosine Deaminase (ADA) deficiency, the patient requires periodic infusion of genetically engineered lymphocytes because:
| 1. | Genetically engineered lymphocytes are not immortal cells. |
| 2. | Retroviral vector is introduced into these lymphocytes. |
| 3. | Gene isolated from marrow cells producing ADA is introduced into cells at embryonic stages |
| 4. | Lymphocytes from patient's blood are grown in culture, outside the body. |
Subtopic: Gene Therapy |
75%
Level 2: 60%+
NEET - 2022
Hints
When gene targeting involving gene amplification is attempted in an individual's tissue to treat disease, it is known as:
| 1. | Molecular diagnosis | 2. | Safety testing |
| 3. | Biopiracy | 4. | Gene therapy |
Subtopic: Gene Therapy |
68%
Level 2: 60%+
NEET - 2021
Hints
The Adenosine deaminase deficiency results into:
| 1. | Digestive disorder | 2. | Addison's disease |
| 3. | Dysfunction of Immune system | 4. | Parkinson's disease |
Subtopic: Gene Therapy |
84%
Level 1: 80%+
NEET - 2021
Hints
Which of the following is commonly used as a vector for introducing a DNA fragment in human Lymphocytes?
1. Retrovirus
2. Ti plasmid
3. λ phage
4. pBR 322
2. Ti plasmid
3. λ phage
4. pBR 322
Subtopic: Gene Therapy |
77%
Level 2: 60%+
NEET - 2018
Hints
- 1(current)
Q. No.
© 2026 GoodEd Technologies Pvt. Ltd.